טוען...
The successful use of dronabinol for failure to thrive secondary to intestinal dysmotility
INTRODUCTION: Symptoms of severe intestinal dysmotility decrease patients’ quality of life and may prevent them from sustaining adequate oral intake. Dronabinol is a synthetic cannabinoid that is labeled for use in AIDS-related anorexia and chemotherapy-associated nausea and vomiting that has additi...
שמור ב:
| הוצא לאור ב: | Int J Surg Case Rep |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4446691/ https://ncbi.nlm.nih.gov/pubmed/25974259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijscr.2015.04.036 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|